Harvard Bioscience Inc HBIO:NASDAQ

Last Price$3.70NASDAQ Previous Close - Last Trade as of 4:00PM ET 7/01/22

Today's Change+0.10(2.78%)
Bid (Size)$1.75 (25)
Ask (Size)$3.82 (2)
Day Low / High$3.59 - 3.75
Volume201.4 K
 

View Biotechnology IndustryPeer Comparison as of 07/01/2022

 

Harvard Bioscience Inc ( NASDAQ )

Price: $3.70
Change: +0.10 (2.78%)
Volume: 201.4 K
4:00PM ET 7/01/2022
 
 

Personalis Inc ( NASDAQ )

Price: $3.40
Change: -0.05 (1.45%)
Volume: 350.6 K
4:00PM ET 7/01/2022
 
 

CorMedix Inc ( NASDAQ )

Price: $3.83
Change: -0.19 (4.73%)
Volume: 334.4 K
4:00PM ET 7/01/2022
 
 

Precision BioSciences Inc ( NASDAQ )

Price: $1.53
Change: -0.07 (4.38%)
Volume: 5.5 M
4:00PM ET 7/01/2022
 
 

Jounce Therapeutics Inc ( NASDAQ )

Price: $3.02
Change: -0.01 (0.33%)
Volume: 107.5 K
4:00PM ET 7/01/2022
 

Read more news Recent News

Insider Buy: Harvard Bioscience
4:32PM ET 6/17/2022 MT Newswires

James W Green, Director, Chief Executive Officer, on June 15, 2022, executed a purchase for 30,000 shares in Harvard Bioscience (HBIO) for $111,300....

-- Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q1 Revenue $28.8M, vs. Street Est of $28.7M
7:04AM ET 5/04/2022 MT Newswires

...

-- Earnings Flash (HBIO) HARVARD BIOSCIENCE Reports Q1 EPS $0.04, vs. Street Est of $0.06
7:04AM ET 5/04/2022 MT Newswires

...

-- Earnings Flash (HBIO) HARVARD BIOSCIENCE Posts Q4 EPS $0.08, vs. Street Est of $0.11
7:01AM ET 3/08/2022 MT Newswires

...

Company Profile

Business DescriptionHarvard Bioscience, Inc. develops, manufactures, and sells technologies, products and services that enable fundamental research, discovery, and pre-clinical testing for drug development. It operates under the geographical segments: United States, Germany, United Kingdom, and Rest of the world. It sells its products through catalog, Website, distributors, and direct sales force. The company was founded by Dr. William T. Porter in 1901 and is headquartered in Holliston, MA. View company web site for more details
Address84 October Hill Road
Holliston, Massachusetts 01746-1371
Phone+1.508.893.8999
Number of Employees547
Recent SEC Filing06/21/2022SC 13G
Chairman, President & Chief Executive OfficerJames W. Green
Chief Financial OfficerMichael A. Rossi
Vice President-Global Sales, Preclinical SystemsRyan Wallace
Chief Marketing OfficerJacques Coumans

Company Highlights

Price Open$3.61
Previous Close$3.60
52 Week Range$3.25 - 8.75
Market Capitalization$152.6 M
Shares Outstanding41.2 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/04/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$0.05
Beta vs. S&P 500N/A
Revenue$120.8 M
Net Profit Margin-5.38%
Return on Equity-8.24%

Analyst Ratings as of 05/19/2022

Buy
3
Overweight
0
Hold
0
Underweight
0
Sell
0
Consensus RecommendationConsensus Icon
Powered by Factset